Interleukin-36
IL36GproteinIL-36 cytokine family member promoting vascular inflammation and atherosclerotic plaque destabilization.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationalePro-atherogenic regulator of vascular inflammation in plaque.
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000136688
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Interleukin-36: a novel therapeutic target for atherosclerosis.Current problems in cardiology · 2025 · PMID 41027491 · doi